Medacta Group Ltd header image

Medacta Group Ltd

MOVE

Equity

ISIN CH0468525222 / Valor 46852522

SIX Swiss Exchange (2026-03-27)

CHF 148.80-1.06%

Medacta Group Ltd
UMushroom community rating:

3.50 2 votes No rating yet

NegativeNeutralPositive

About company

Medacta Group Ltd is a Switzerland‑based medical device company that designs, manufactures and commercializes orthopedic implants, instruments and surgical guidance solutions for hip, knee, shoulder and spine procedures. Its offering combines implant technologies—including conventional and additively manufactured components—with patient‑specific planning and intraoperative guidance tools and protocols, and the firm runs surgeon education and training programs to support clinical adoption of its techniques (notably an anterior approach for hip replacement). Medacta supplies hospitals and clinics worldwide through its commercial network, providing implants, instrumentation, digital planning services and related consumables for joint reconstruction and spine care.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

13.1%1Y

51.1%3Y

42.0%5Y

Performance

28.5%1Y

27.7%3Y

31.9%5Y

Volatility

3710 M

Market cap (USD)

9,162

Daily traded volume (Shares)

108.4 / 107

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.50

2 votes

Performance:

3.25

Innovation:

3.25

Society:

3.25

Nature:

3.50

Carmen Winter

Switzerland, 15 Apr 2025

-

Mario Mueller

Switzerland, 20 Oct 2022

EQUITIES OF THE SAME SECTOR

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc Valor: 23194616

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 131.87

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-7.98%USD 18.16

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

-3.23%USD 69.23

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-1.73%USD 27.27

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

1.56%EUR 26.00

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.57%EUR 78.90

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.10%CHF 312.50

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

-1.56%USD 510.68

Evotec SE

Evotec SE Valor: 505433

Annual Return

-50%0%+50%

Risk level

110

-1.60%EUR 4.30

Limes Schlosskliniken AG

Limes Schlosskliniken AG Valor: 38625581

Annual Return

-50%0%+50%

Risk level

110

-0.83%EUR 476.00

SIX

FactSet

Clearbit

Logos provided by Clearbit